A detailed history of Profund Advisors LLC transactions in Liquidia Corp stock. As of the latest transaction made, Profund Advisors LLC holds 12,942 shares of LQDA stock, worth $149,221. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,942
Previous 14,434 10.34%
Holding current value
$149,221
Previous $173,000 25.43%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$8.9 - $14.11 $13,278 - $21,052
-1,492 Reduced 10.34%
12,942 $129,000
Q2 2024

Aug 13, 2024

BUY
$11.96 - $15.71 $41,453 - $54,450
3,466 Added 31.6%
14,434 $173,000
Q1 2024

May 08, 2024

BUY
$11.35 - $16.73 $124,486 - $183,494
10,968 New
10,968 $161,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $742M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.